Description
HYALUAL Xela Rederm 1.8% 1x2ml is a sterile injectable skin revitalisation treatment developed by Hyalual Group as part of its Redermalization® range. The product combines non-cross-linked hyaluronic acid with sodium succinate, creating a dual-action formulation designed to support skin hydration and improve overall skin quality.
The formulation contains 18 mg/ml hyaluronic acid (1.8%) and 16 mg/ml sodium succinate. Hyaluronic acid contributes to water retention within the extracellular matrix and supports skin hydration, while sodium succinate forms part of the manufacturer’s proprietary Redermalization® concept associated with cellular metabolic activity and antioxidant support.
Positioned between the lower-strength Xela Rederm 1.1% and higher-concentration Xela Rederm 2.2%, the 1.8% formulation is intended for patients presenting with moderate skin dehydration, reduced elasticity, and visible age-related skin changes. The product is supplied in a sterile 2 ml syringe and is intended exclusively for professional administration by qualified healthcare practitioners.
What HYALUAL Xela Rederm 1.8% Is Similar To
HYALUAL Xela Rederm 1.8% belongs to the category of injectable skin boosters and biorevitalisation treatments designed to improve skin quality rather than create facial volume. Comparable products include Profhilo®, Jalupro®, Sunekos®, and other hyaluronic acid-based skin revitalisation therapies.
Like Profhilo®, Xela Rederm aims to improve hydration and skin quality through hyaluronic acid delivery. However, the technologies differ considerably. Profhilo contains stabilised hyaluronic acid complexes, whereas Xela Rederm combines non-cross-linked hyaluronic acid with sodium succinate as part of the Redermalization® concept.[1][3]
Compared with Sunekos®, which combines hyaluronic acid with amino acid complexes, Xela Rederm uses sodium succinate as its secondary active component. Both product categories are intended to support skin quality improvement but utilise different biological approaches.[4]
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to available manufacturer and distributor documentation, HYALUAL Xela Rederm 1.8% may be used in aesthetic skin revitalisation procedures involving:
- Face
- Neck
- Décolletage
- Hands
Potential aesthetic indications include:
- Skin dehydration
- Reduced elasticity
- Uneven skin texture
- Dull skin appearance
- Visible signs of ageing
- Skin quality improvement protocols
Treatment planning should be determined by qualified healthcare professionals based on individual patient assessment.
Usage / Administration (IFU-Only Section)
According to publicly available manufacturer information:
Injection depth: Superficial dermis.
Professional-use disclaimer: HYALUAL Xela Rederm 1.8% should be administered only by qualified medical professionals trained in aesthetic injection procedures and aseptic techniques.[1]
Some practitioners utilise personalised injection patterns and treatment schedules; however, these approaches are not included within publicly available manufacturer IFU documentation and should not be considered official manufacturer guidance.
Ingredient List
Active Ingredients
- Non-cross-linked hyaluronic acid – 18 mg/ml (1.8%)
- Sodium succinate – 16 mg/ml
Excipients
- Phosphate buffer solution
- Water for injection
Hyaluronic Acid Concentration
- 18 mg/ml (1.8%)
Presentation & Longevity
Presentation
- 1 × 2 ml sterile prefilled syringe
- Single-use injectable product
- Professional-use packaging
Longevity
Treatment duration and persistence are not specified within publicly available manufacturer information. Clinical outcomes may vary according to patient characteristics, treatment objectives, skin condition, and practitioner technique.
Any longevity estimates referenced in clinical practice should not be interpreted as manufacturer-guaranteed outcomes.
Safety Notes / Contraindications
According to manufacturer information and standard injectable treatment precautions:
- Contraindicated in patients with hypersensitivity to hyaluronic acid, sodium succinate, or any formulation component.
- Should not be administered into areas affected by active infection, inflammation, or skin disease.
- Not intended for intravascular administration.
- Must be administered only by appropriately trained healthcare professionals.
Patients should undergo an appropriate medical consultation before treatment to determine suitability.
Regulatory Status
Manufacturer: Hyalual Group.
Regulatory Status: CE-marked medical device according to manufacturer and authorised distributor documentation.
Practitioners should verify current regulatory approvals, product registration, and local compliance requirements through official documentation and relevant regulatory databases.
FAQ
1. What is HYALUAL Xela Rederm 1.8% used for?
HYALUAL Xela Rederm 1.8% is an injectable skin revitalisation treatment intended to improve skin hydration and support overall skin quality. It combines non-cross-linked hyaluronic acid with sodium succinate and is commonly incorporated into professional aesthetic protocols targeting visible signs of skin ageing, dehydration, and reduced elasticity.
2. How does Xela Rederm 1.8% differ from Xela Rederm 1.1% and 2.2%?
The primary difference is the concentration of hyaluronic acid. Xela Rederm 1.1% contains 11 mg/ml HA, Xela Rederm 1.8% contains 18 mg/ml HA, and Xela Rederm 2.2% contains 22 mg/ml HA. All formulations contain sodium succinate and are based on the same Redermalization® technology platform.
3. What role does sodium succinate play in the formulation?
According to manufacturer information, sodium succinate is incorporated as part of the Redermalization® concept. It participates in cellular metabolic pathways and represents a distinguishing characteristic of the Xela Rederm range compared with many conventional hyaluronic acid skin boosters.
4. Is HYALUAL Xela Rederm 1.8% a dermal filler?
No. Although the product contains hyaluronic acid, it is generally classified as a skin booster or biorevitalisation treatment rather than a volumising dermal filler. Its primary objective is improvement of skin quality and hydration rather than facial contour restoration.
5. Does HYALUAL Xela Rederm 1.8% contain lidocaine?
No. Available manufacturer and distributor information indicates that HYALUAL Xela Rederm 1.8% does not contain lidocaine. Practitioners should always verify formulation details against the latest Instructions for Use and product packaging before administration.
